A single ascending-dose study of muscle regulator ace-031 in healthy volunteers von Attie, Kenneth M., Borgstein, Niels G., Yang, Yijun, Condon, Carolyn H., Wilson, Dawn M., Pearsall, Amelia E., Kumar, Ravi, Willins, Debbie A., Seehra, Jas S., Sherman, Matthew L.

Volltext

Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women von Sherman, Matthew L., Borgstein, Niels G., Mook, Louisa, Wilson, Dawn, Yang, Yijun, Chen, Nianhang, Kumar, Ravindra, Kim, Kenneth, Laadem, Abderrahmane

Volltext

Long-Term Tolerability of Tolterodine Extended Release in Children 5–11 Years of Age: Results from a 12-Month, Open-Label Study von Nijman, Rien J.M, Borgstein, Niels G, Ellsworth, Pamela, Siggaard, Charlotte

Volltext

Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity von Reddy, Pramod P, Borgstein, Niels G, Nijman, Rien J.M, Ellsworth, Pamela I

Volltext

ACE-011, a Soluble Activin Receptor Type Iia IgG-Fc Fusion Protein, Increases Hemoglobin (Hb) and Improves Bone Lesions in Multiple Myeloma Patients Receiving Myelosuppressive Chem... von Abdulkadyrov, Kudrat M., Salogub, Galina N., Khuazheva, Nuriet K., Woolf, Rachel, Haltom, Eric, Borgstein, Niels G., Knight, Robert, Renshaw, Gary, Yang, Yijun, Sherman, Matthew L.

Volltext

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer von Beer, Tomasz M, Vogelzang, Nicholas, Bartůňková, Jiřina, Miller, Kurt, Oh, William, Oudard, Stephane, Pandha, Hardev, Sartor, A Oliver, Špíšek, Radek, Toole, Timothy O, Borgstein, Niels G, Gerritsen, Winald R

Volltext

Autologous dendritic cell immunotherapy prostate cancer von Beer, Tomasz M, Vogelzang, Nicholas, BartůÅková, JiÅina, Miller, Kurt, Oh, William, Oudard, Stephane, Pandha, Hardev, Sartor, A Oliver, SpíÅ¡ek, Radek, Toole, Timothy O, Borgstein, Niels G, Gerritsen, Winald R

Volltext

ACE-011, a Soluble Activin Receptor Type IIa IgG-Fc Fusion Protein, Increases Hemoglobin and Hematocrit Levels in Postmenopausal Healthy Women von Kim, Kenneth T, Borgstein, Niels G, Yang, Yijun, Haltom, Eric, Mook, Louisa, Ababa, Michelle D, Reddy, Sandeep K, Sherman, Matthew Leigh

Volltext

Long-term tolerability of tolterodine extended release in children 5-11 years of age : Results from a 12-month, open-label study. Commentary von NIJMAN, Rien J. M, BORGSTEIN, Niels G, ELLSWORTH, Pamela, SIGGAARD, Charlotte, BURGER, Maximilian

Volltext